State of Wisconsin Investment Board’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
200,279
+14,856
+8% +$85.7K ﹤0.01% 1661
2025
Q4
$996K Buy
185,423
+144,023
+348% +$665K ﹤0.01% 1683
2025
Q3
$145K Buy
+41,400
New +$131K ﹤0.01% 2296
2025
Q2
Sell
-47,700
Closed -$90.6K 2338
2025
Q1
$90.6K Buy
+47,700
New +$127K ﹤0.01% 2179
2023
Q3
Sell
-11,601
Closed -$34.6K 2524
2023
Q2
$34.6K Sell
11,601
-58,255
-83% -$183K ﹤0.01% 2281
2023
Q1
$224K Buy
+69,856
New +$274K ﹤0.01% 2213

Other funds holding CMPX

State of Wisconsin Investment Board's CMPX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Compass Therapeutics (CMPX) stake by 8% in Q1 2026, buying an estimated $85.7K and bringing the position to 200,279 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

State of Wisconsin Investment Board first reported a position in CMPX in Q1 2023 and has held it in 6 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • State of Wisconsin Investment Board held 200,279 shares of Compass Therapeutics worth $1.06M as of Q1 2026.
  • State of Wisconsin Investment Board bought 14,856 Compass Therapeutics shares in Q1 2026, an estimated $85.7K.
  • Compass Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1661 holding.
  • State of Wisconsin Investment Board first reported a position in Compass Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.